30 Aug 2022
Neuroendocrine cancer pertinent cancer susceptibility v1.4
SDHA
Arina Puzriakova Phenotypes for gene: SDHA were changed from Neuroendocrine cancer to Paragangliomas 5, OMIM:614165
30 Aug 2022
Neuroendocrine cancer pertinent cancer susceptibility v1.3
SDHB
Arina Puzriakova Phenotypes for gene: SDHB were changed from Neuroendocrine cancer to Paragangliomas 4, OMIM:115310; Pheochromocytoma, OMIM:171300; Paraganglioma and gastric stromal sarcoma, OMIM:606864
28 Jul 2021
Neuroendocrine cancer pertinent cancer susceptibility v1.2
CDKN1B
Arina Puzriakova Phenotypes for gene: CDKN1B were changed from Neuroendocrine cancer to Multiple endocrine neoplasia, type IV, OMIM:610755
18 Jun 2021
Neuroendocrine cancer pertinent cancer susceptibility v1.1
MAX
Arina Puzriakova Phenotypes for gene: MAX were changed from Neuroendocrine cancer to {Pheochromocytoma, susceptibility to}, OMIM:171300
07 Sep 2018
Neuroendocrine cancer pertinent cancer susceptibility v1.0
Louise Daugherty promoted panel to version 1.0
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
Ellen McDonagh approved panel
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
VHL
Ellen McDonagh classified VHL as green
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
VHL
Ellen McDonagh commented on VHL
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
TMEM127
Ellen McDonagh classified TMEM127 as green
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
TMEM127
Ellen McDonagh commented on TMEM127
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHD
Ellen McDonagh classified SDHD as green
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHD
Ellen McDonagh commented on SDHD
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHC
Ellen McDonagh classified SDHC as green
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHC
Ellen McDonagh commented on SDHC
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHB
Ellen McDonagh classified SDHB as green
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHB
Ellen McDonagh commented on SDHB
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHAF2
Ellen McDonagh classified SDHAF2 as green
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHAF2
Ellen McDonagh commented on SDHAF2
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHA
Ellen McDonagh classified SDHA as green
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHA
Ellen McDonagh commented on SDHA
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
RET
Ellen McDonagh classified RET as green
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
RET
Ellen McDonagh commented on RET
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
MEN1
Ellen McDonagh classified MEN1 as green
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
MEN1
Ellen McDonagh commented on MEN1
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
MAX
Ellen McDonagh classified MAX as green
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
MAX
Ellen McDonagh commented on MAX
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
FH
Ellen McDonagh classified FH as green
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
FH
Ellen McDonagh commented on FH
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
CDKN1B
Ellen McDonagh commented on CDKN1B
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
CDKN1B
Ellen McDonagh classified CDKN1B as green
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
FH
Clare Turnbull reviewed FH
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
VHL
Clare Turnbull reviewed VHL
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
TMEM127
Clare Turnbull reviewed TMEM127
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHD
Clare Turnbull reviewed SDHD
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHC
Clare Turnbull reviewed SDHC
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHB
Clare Turnbull reviewed SDHB
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHAF2
Clare Turnbull reviewed SDHAF2
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
SDHA
Clare Turnbull reviewed SDHA
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
RET
Clare Turnbull reviewed RET
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
MEN1
Clare Turnbull reviewed MEN1
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
MAX
Clare Turnbull reviewed MAX
26 Jul 2017
Neuroendocrine cancer pertinent cancer susceptibility
CDKN1B
Clare Turnbull reviewed CDKN1B